Theravance Biopharma (TBPH) Return on Assets [ROA] (2014 - 2026)
Theravance Biopharma's Return on Assets [ROA] came in at 11.41% for Q2 2026, up 8.03 percentage points from 3.39% a year earlier but down 12.49 percentage points from the prior quarter.
Powered by 
Analysis
Theravance Biopharma (TBPH) Return on Assets [ROA] (2014 - 2026) Analysis & Trends
For FY2025, Theravance Biopharma's Return on Assets [ROA] was 25.21%, up 40.54 percentage points from FY2024.
- Return on Assets [ROA] carries a five-year change of +88.55 percentage points (FY2020 to FY2025).
- Going back by year, Return on Assets [ROA] was -15.33% in FY2024 (-4.17 pp), -11.16% in FY2023 (-188.74 pp), 177.58% in FY2022 (+224.85 pp) and -47.26% in FY2021 (+16.07 pp).
- The five-year range for quarterly Return on Assets [ROA] is -58.30% (Q3 2021) to 176.32% (Q2 2023).
- Year-over-year, Return on Assets [ROA] has increased for five consecutive quarters, with an average year-over-year change of +14.66 percentage points over the last eight quarters.
- The fastest year-over-year change in Return on Assets [ROA] over five years came in Q3 2022 (a gain of 209.59 percentage points), and the weakest in Q2 2024 (a drop of 188.77 percentage points).
- Business Quant data shows TBPH's Return on Assets [ROA] at 23.91% (Q1 2026), 23.49% (Q4 2025) and 6.97% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 10.47% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 4.65% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.45% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 28.37% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 9.10% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 9.29% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -6.13% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 2.14% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 16.34% |
| 10 | Theravance Biopharma | 883.70 Mn | -543.66 Mn | - | 11.41% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.41% |
| Mar 31, 2026 | 23.91% |
| Dec 31, 2025 | 23.49% |
| Sep 30, 2025 | 6.97% |
| Jun 30, 2025 | 3.39% |
| Mar 31, 2025 | -16.72% |
| Dec 31, 2024 | -15.89% |
| Sep 30, 2024 | -13.76% |
| Jun 30, 2024 | -12.45% |
| Mar 31, 2024 | -11.89% |
| Dec 31, 2023 | -13.87% |
| Sep 30, 2023 | -13.26% |
| Jun 30, 2023 | 176.32% |
| Mar 31, 2023 | 152.88% |
| Dec 31, 2022 | 127.24% |
| Sep 30, 2022 | 151.29% |
| Jun 30, 2022 | -28.34% |
| Mar 31, 2022 | -39.91% |
| Dec 31, 2021 | -51.27% |
| Sep 30, 2021 | -58.30% |
API Access
Theravance Biopharma Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=TBPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "TBPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=TBPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();